简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-03-25 09:47 Waters Peptide Multi-Attribute Method for BioAccord System Boosts Innovator and Biosimilar Drug Development and Commercialization
2021-03-24 17:35 Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
2021-03-24 16:51 USAble Life Installs FINEOS Platform for Integrated Disability and Absence Management
2021-03-23 16:46 Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry
2021-03-22 18:56 HempFusion Wellness Enters China with Probulin Probiotics Through Alibaba Group’s Tmall Global, Reaching More Than 750 Million Potential New Consumers
2021-03-22 16:47 The Centers for Disease Control and Prevention (CDC) Updates Handwashing Guidelines and Materials
2021-03-22 15:00 Yokogawa Establishes Yokogawa Bio Frontier Inc. to Advance Biomass Materials Business
2021-03-19 14:39 SpeeDx Increase Distribution Network
2021-03-19 10:04 LianBio Announces Appointment of Yi Larson as Chief Financial Officer
2021-03-18 18:52 Grand Prize Winners Selected in $6M XPRIZE Rapid Covid Testing Competition to Create Fast, Frequent, Cheap, and Easy-to-Use Solutions
2021-03-17 18:27 PCI Pharma Broadens Clinical Trial Service Offerings at Berlin Facility, Bringing Worldwide Access to Clients in the European Union
2021-03-17 18:24 Kaye Launches LabWatch® IoT - An Intelligent, Cloud Based Monitoring/Alarming System Designed to Protect Critical GxP Products and Ensure Patient Safety
2021-03-17 09:53 Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
2021-03-17 09:45 New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy
2021-03-16 10:04 Takeda’s Growth and Emerging Markets Business Unit Aims to Deliver Double-Digit Revenue Growth Over Next Decade1
2021-03-16 09:41 Landmark Long-Term Data from EORTC’s MINDACT Study Published in The Lancet Oncology
2021-03-16 09:31 Subgroup Analysis from Phase 3 Clinical Trial Supports Efficacy of Maribavir Over Conventional Therapies in Transplant Recipients With Cytomegalovirus Infection (Refractory, With or Without Resistance)
2021-03-15 09:44 IKEA Foundation Supports UN Campaign for Equitable, Global COVID-19 Vaccine Access
2021-03-12 17:13 Mevion Joins Partnership to Open the First Children’s Proton Center in China
2021-03-12 15:44 Global Immunization Possible by 2022 With Fair Vaccine Distribution, Says WHO COVID-19 Special Envoy

Business Wire Weibo

Press Releases

Latest Releases